Results per Page:
A foamy way to improve cost, efficiency and safety of gene therapy
From the Stephan Lab, Translational Science and Therapeutics Division
Taking a frothy risk to advance gene therapy
Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Could a medicated foam make gene therapies more accessible?
In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.